Brimonidine Tartrate (Sandoz Inc)
Welcome to the PulseAid listing for the Brimonidine Tartrate drug offered from Sandoz Inc. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Brimonidine Tartrate |
SUBSTANCE NAME: | BRIMONIDINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2003-09-17 |
END MARKETING DATE: | 0000-00-00 |
Brimonidine Tartrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Brimonidine Tartrate from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2003-09-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-143_2d66fa03-f6c8-4eac-9f78-5072ef84e3d3 |
PRODUCT NDC: | 61314-143 |
APPLICATION NUMBER: | ANDA076254 |
Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers: